1. Waddell T, Verheij M, Allum W et al. European Society for Medical Oncology (ESMO); European Society of Surgical Oncology (ESSO); European Society of Radiotherapy and Oncology (ESTRO). Eur J Surg Oncol 2014; 40 (5): 584–91.
2. Щербаков П.Л., Потапов А.С., Дублина Е.С. и др. Схемы эрадикации штаммов Helicobacter pylori, резистентных к метронидазолу у детей. Вопросы современной педиатрии. 2007; 6 (5): 100–4.
3. Emin-Kurekci A, Avni-Atay A, Umit-Sarici S et al. Is there a relationship between childhood Helicobacter pylori infection and iron deficiency anemia? J Trop Pediatr 2005; 51: 166–69.
4. Koletzko S, Jones NL, Goodman KJ et al. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. H. pylori Working Groups of ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr 2011; 53 (2): 230–43.
5. Malfertheiner P, Megraud F, O’Morain C et al. Management of Helicobacter pylori infection – Maastricht IV. Florence consensus report. Gut 2012; 61: 646–64.
6. Кудрявцева Л.В. Состояние антибиотикорезистентности H. pylori в России. Эксперим. и клин. гастроэнтерол. 2003; 3: 4–5.
7. Lesbros-Pantoflickova D, Corthesy-Theulaz I, Blum AL. Helicobacter pylori and probiotics. J Nutr 2007; 137 (2): 812–8.
8. Alsahli M, Michetti P. Lactobacilli for the management of Helicobacter pylori. Nutrition 2001; 17: 268–9.
9. Vandenbergh PA. Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol Rev 1993; 12: 221–38.
10. Midolo PD, Lambert JR, Hull R et al. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol 1995; 79: 475–9.
11. Guruge JL, Falk PG, Lorenz RG et al. Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci USA 1998; 95: 3925–30.
12. Mukai T, Asasaka T, Sato E et al. Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol Med Microbiol 2002; 32: 105–10.
13. Byrd JC, Yunker CK, Xu QS et al. Inhibition of gastric mucin synthesis by Helicobacter pylori. Gastroenterol 2000; 118: 1072–9.
14. Mack DR, Michail S, Wei S et al. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999; 276: 941–50.
15. Gill HS. Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2003; 17: 755–73.
16. Sykora J, Valeckova K, Amlerova J et al. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol 2005; 39: 692–8.
17. Goldman CG, Barrado DA, Balcarce N et al. Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children. Nutrition 2006; 22: 984–8.
18. Lionetti E, Miniello VL, Castellaneta SP et al. Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial. Aliment Pharmacol Ther 2006; 24: 1461–8.
19. Cruchet S, Obregon MC, Salazar G et al. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition 2003; 19: 716–21.
20. Gotteland M, Poliak L, Cruchet S, Brunser O. Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus LB in children colonized by Helicobacter pylori. Acta Pediatr 2005; 94: 1747–51.
21. Kelly SM, Pitcher MC, Farmery SM, Gibson GR. Isolation of Helicobacter pylori from feces of patients with dyspepsia in the United Kingdom. Gastroenterology 1994; 107 (6): 1671–4.
22. Falsafi T, Valizadeh N, Najafi M et al. Culture of Helicobacter pylori from stool samples in children. Can J Microbiol 2007; 53 (3): 411–6.
23. Szajewska H et al. Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. Aliment Pharmacol & Therapeutics 2010; 32 (9): 1069–79.
24. Zhao HM, Ou-Yang HJ, Duan BP et al. Clinical effect of triple therapy combined with Saccharomyces boulardii in the treatment of Helicobacter pylori infection in children. Chin J Cont Pediatr 2014; 16 (3): 230–3.

Н.Н.Дехнич1, Н.В.Иванчик2

1 Кафедра факультетской терапии ГБОУ ВПО Смоленская государственная медицинская академия Минздрава России;
2 НИИ антимикробной химиотерапии ГБОУ ВПО Смоленская государственная медицинская академия Минздрава России